Ponoi Capital II, LP

10% owner at CONSTAR INTERNATIONAL INC · on record since Jul 23, 2018
10% owner at NGM BIOPHARMACEUTICALS INC · on record since Jun 26, 2019
10% owner at Revolution Medicines, Inc. · on record since Feb 18, 2020
10% owner at Nurix Therapeutics, Inc. · on record since Jul 29, 2020
10% owner at RAPT Therapeutics, Inc. · on record since Oct 30, 2019

Insider trading activity of Ponoi Capital II, LP

Transactions on record: 41; since May 22, 2019

Open-market buys: 19; $14.6M

Open-market sells: 3; $319.4K

Companies traded: 2; last filing Feb 1, 2023

Figures computed from official regulatory filings — .

Companies where Ponoi Capital II, LP has traded

NGM BIOPHARMACEUTICALS INC18 tx · $7.1M · Feb 1, 2023
RAPT Therapeutics, Inc.23 tx · $8.1M · Sep 29, 2021

Track record of Ponoi Capital II, LP

Open-market buys: 19

Last buy: Jan 31, 2023

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of Ponoi Capital II, LP

Co-insiders of Ponoi Capital II, LP

Kutzkey TimCONSTAR INTERNATIONAL INC +4

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 1, 2023	Buy	7,542	5.00 USD	$37.7K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 1, 2023	Buy	176,730	5.00 USD	$883.7K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Oct 31, 2022	Buy	76,877	4.86 USD	$373.6K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Oct 27, 2022	Buy	51,046	4.75 USD	$242.5K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Oct 27, 2022	Buy	72,774	4.85 USD	$353K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	32,072	12.90 USD	$413.7K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	1,094	12.90 USD	$14.1K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	4,269	—	—	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	125,096	—	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Sell	-1,114	34.97 USD	$39K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	ExerciseD (derivative)	-625	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Exercise	7,500	28.27 USD	$212K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Sell	-625	34.94 USD	$21.8K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	ExerciseD (derivative)	-7,500	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	ExerciseD (derivative)	-1,114	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Sell	-7,500	34.48 USD	$258.6K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Exercise	1,114	22.20 USD	$24.7K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Exercise	625	19.30 USD	$12.1K	SEC
RAPT Therapeutics, Inc.Listing unverified	Jun 22, 2020	OtherD (derivative)	22,500	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Mar 25, 2020	Buy	170,387	11.63 USD	$2M	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Mar 25, 2020	Buy	128,377	12.22 USD	$1.6M	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Mar 25, 2020	Buy	2,416	12.49 USD	$30.2K	SEC
RAPT Therapeutics, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-14,781,963	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Nov 4, 2019	Other	727,008	—	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-4,362,050	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 1, 2023	Buy	7,542	5.00 USD	$37.7K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 1, 2023	Buy	176,730	5.00 USD	$883.7K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Oct 31, 2022	Buy	76,877	4.86 USD	$373.6K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Oct 27, 2022	Buy	51,046	4.75 USD	$242.5K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Oct 27, 2022	Buy	72,774	4.85 USD	$353K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	32,072	12.90 USD	$413.7K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	1,094	12.90 USD	$14.1K	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	4,269	—	—	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 17, 2022	Buy	125,096	—	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Sell	-1,114	34.97 USD	$39K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	ExerciseD (derivative)	-625	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Exercise	7,500	28.27 USD	$212K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Sell	-625	34.94 USD	$21.8K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	ExerciseD (derivative)	-7,500	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	ExerciseD (derivative)	-1,114	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Sell	-7,500	34.48 USD	$258.6K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Exercise	1,114	22.20 USD	$24.7K	SEC
RAPT Therapeutics, Inc.Listing unverified	Sep 29, 2021	Exercise	625	19.30 USD	$12.1K	SEC
RAPT Therapeutics, Inc.Listing unverified	Jun 22, 2020	OtherD (derivative)	22,500	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Mar 25, 2020	Buy	170,387	11.63 USD	$2M	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Mar 25, 2020	Buy	128,377	12.22 USD	$1.6M	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Mar 25, 2020	Buy	2,416	12.49 USD	$30.2K	SEC
RAPT Therapeutics, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-14,781,963	0.00 USD	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Nov 4, 2019	Other	727,008	—	—	SEC
RAPT Therapeutics, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-4,362,050	0.00 USD	—	SEC